Analysis of Toll-like receptor families participating in the Kawasaki disease and application to a treatment
Analysis of Toll-like receptor families participating in the Kawasaki disease and application to a treatment
批准号:
15591116
负责人:
NISHIMURA Shinji
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We extracted DNA from whole blood of 69 control children and 67 Kawasaki disease(KD). We determined a polymorphism in the CD14 gene at -159 upstream from the major transcription site (CD14/-159 ) by restriction fragment assay. We then investigated the association between CD14/-159 and onset of KD and development of coronary artery lesion(CAL). The genomic and allelic frequencies of the polymorphism were not different between normal children and KD patients. The KD patients with TT genotypes at CD14/-159 had more CAL complications than those with CT and CC (OR,4.05;95% CI,1.34-12.22). The frequencies of the T allele was significantly higher than that of C allele in KD patients with CAL ( OR,2.20;95% CI,1.23-3.94). Their data were confirmed in the patients whether the patients were treated with intravenous gamma-globulin. KD patients with TT genotypes had significantly higher levels of C-reacting protein and vascular endothelial growth factor, which had previously been reported as risk factor for CAL, than those with CC genotypes. These results indicate that the T allele and TT genotype at CD14/-159 are risk factors for CAL in KD, and that the development of CAL in KD may be related to the magnitude of CD14-toll-like receptor response.We were not able to point out the gene seasonal polymorphism about a TLR2 gene and gene seasonal polymorphism of a TLR4 gene. It was thought that this genetic gene seasonal t polymorphism was different with Japanese.The expression of RP105 on B lymphocytes in acute phase of Kawasaki disease let you suggest the possibility that a specific function of RP105 affected the condition of a patient of this disease.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Shinji Nishimura: "A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesion in patients with Kawasaki disease"The Journal of Pediatrics. 143. 357-362 (2003)
Shinji Nishimura:“CD14 基因 (CD14/-159) 启动子的多态性与川崎病患者冠状动脉病变的发生有关”《儿科学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1067/s0022-3476(03)00330-5
发表时间:
2003-09-01
期刊:
JOURNAL OF PEDIATRICS
影响因子:
5.1
作者:
[Nishimura, S, Zaitsu, M, Hamasaki, Y]
通讯作者:
Hamasaki, Y
Analysis of signaling via Toll-like receptors in Kawasaki disease
-
批准号:18591158
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:2006
-
负责人:NISHIMURA Shinji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
MHC-I/CD14介导CD8+T细胞免疫抑制促进去势抵抗前列腺癌免疫逃逸的研究
-
批准号:2026JJ50277
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟上伟
-
依托单位:
磷脂代谢紊乱与CD14互作加重肺纤维化重叠间歇低氧病理损伤分子机制研究
-
批准号:82300120
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘丹
-
依托单位:
膜蛋白CD14介导的双歧杆菌胞外多糖调控成骨细胞代谢的分子机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:尚楠
-
依托单位:
可溶性CD14与CD55协同促进围生期巨细胞病毒入侵未成熟胆管细胞致胆管损伤机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:苏亮
-
依托单位:
BPIFA1 通过调控CD14/MyD88 轴参与鼻咽癌发生发展的机制研究
-
批准号:2021JJ30422
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陈攀
-
依托单位:
伯氏疏螺旋体持续激活小胶质细胞“TLR1/2--FR-β-CD14正反馈环路”引起神经莱姆病及滇产天然产物雪胆甲素拮抗作用的机制研究
-
批准号:32060180
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:宝福凯
-
依托单位:
糖调节蛋白78通过结合CD14参与免疫炎症消退的功能及机制研究
-
批准号:81871307
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:雷萍
-
依托单位:
基于蛋白相互作用的CD14多肽类抑制剂的设计及其对脓毒血症的药理作用研究
-
批准号:81803345
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:吴迪
-
依托单位:
FSTL1介由DIP2A/CD14对抗主动脉瓣钙化的机制研究
-
批准号:81770384
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:杨克
-
依托单位:
Nef通过与CD14相互作用激活TLR4信号通路从而调控HIV-1复制的分子机制研究
-
批准号:81601764
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘为勇
-
依托单位: